Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Clinical trial NCT06931340 · RECRUITING

Trial details

NCT number: NCT06931340
Sponsor: Alliance for Clinical Trials in Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Castration-Sensitive Prostate Carcinoma Metastatic Prostate Adenocarcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2025-12-01
Primary completion: 2031-11-11
Enrollment: 1260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.